The research presented in this paper explores the effect of Open Innovation (OI) on firm performance in the biotech-pharma industry sector. Specifically, although existing researches on OI effectiveness have separately investigated the effect of OI practices on innovation and financial performance, this study evaluates the concurrent effect of all those practices on both such performance dimensions in a single framework. We claim the importance for a manager to explore concurrently the influence of specific OI practices both on innovation and economic-financial performance. We empirically test our framework on a sample of 120 companies listed on NASDAQ Biotechnology Index.
Mazzola, E., Bruccoleri, M., & Perrone, G. (2012). Open Innovation practices on firm performance: evidences from biotech industry. In Joint World Conference on Production & Operations Management/International Annual EurOMA Conference, 1-5 July 2012 -Amsterdam, Netherlands (pp.1-10).
Autori: | Mazzola, E.; Bruccoleri, M.; Perrone, G. |
Titolo: | Open Innovation practices on firm performance: evidences from biotech industry |
Data di creazione: | 2012 |
Nome del convegno: | Joint World Conference on Production & Operations Management/International Annual EurOMA Conference |
Luogo del convegno: | Amsterdam, Netherlands |
Anno del convegno: | 1-5 July |
Numero del convegno: | 4th |
Data di pubblicazione: | 2012 |
Numero di pagine: | 10 |
Citazione: | Mazzola, E., Bruccoleri, M., & Perrone, G. (2012). Open Innovation practices on firm performance: evidences from biotech industry. In Joint World Conference on Production & Operations Management/International Annual EurOMA Conference, 1-5 July 2012 -Amsterdam, Netherlands (pp.1-10). |
Tipologia: | 0 - Proceedings (TIPOLOGIA NON ATTIVA) |
Appare nelle tipologie: | 0 - Proceedings (TIPOLOGIA NON ATTIVA) |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
Mazzola et al. 2012_Euroma 2012 Full paper.docx | N/A | Administrator Richiedi una copia |